Pharmacokinetics, Efficacy and Safety of the 304 Injection

Summary

The purpose of this study is to evaluate the pharmacokinetic of the experimental drug 304 injection compared with rituximab injection in patients with CD20 positive B-cell non-Hodgkin lymphoma who had previously achieved CR/CRu status but had not deteriorated or relapsed. While to assess the safety and efficacy of the experimental drug 304 injection compared with rituximab injection.

Timeline

Start

2018-12-18

Primary completion

2019-06-30

Completion

2019-10-31

Drugs

Indications